151 related articles for article (PubMed ID: 17579208)
1. RhoA/Rho kinase blocks muscle differentiation via serine phosphorylation of insulin receptor substrate-1 and -2.
Lim MJ; Choi KJ; Ding Y; Kim JH; Kim BS; Kim YH; Lee J; Choe W; Kang I; Ha J; Yoon KS; Kim SS
Mol Endocrinol; 2007 Sep; 21(9):2282-93. PubMed ID: 17579208
[TBL] [Abstract][Full Text] [Related]
2. Active Rho kinase (ROK-alpha ) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells.
Begum N; Sandu OA; Ito M; Lohmann SM; Smolenski A
J Biol Chem; 2002 Feb; 277(8):6214-22. PubMed ID: 11739394
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix controls insulin signaling in mammary epithelial cells through the RhoA/Rok pathway.
Lee YJ; Hsu TC; Du JY; Valentijn AJ; Wu TY; Cheng CF; Yang Z; Streuli CH
J Cell Physiol; 2009 Aug; 220(2):476-84. PubMed ID: 19391109
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the RhoA/Rho kinase system attenuates catecholamine biosynthesis in PC 12 rat pheochromocytoma cells.
Fukuda T; Takekoshi K; Nanmoku T; Ishii K; Isobe K; Kawakami Y
Biochim Biophys Acta; 2005 Oct; 1726(1):28-33. PubMed ID: 16219424
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase.
Xu JW; Morita I; Ikeda K; Miki T; Yamori Y
Mol Endocrinol; 2007 Feb; 21(2):564-73. PubMed ID: 17095576
[TBL] [Abstract][Full Text] [Related]
6. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G830-7. PubMed ID: 16763289
[TBL] [Abstract][Full Text] [Related]
7. Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.
Delahaye L; Mothe-Satney I; Myers MG; White MF; Van Obberghen E
Endocrinology; 1998 Dec; 139(12):4911-9. PubMed ID: 9832428
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.
Sarbassov DD; Peterson CA
Mol Endocrinol; 1998 Dec; 12(12):1870-8. PubMed ID: 9849961
[TBL] [Abstract][Full Text] [Related]
9. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
11. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
[TBL] [Abstract][Full Text] [Related]
12. Role of Rho-kinase in regulation of insulin action and glucose homeostasis.
Furukawa N; Ongusaha P; Jahng WJ; Araki K; Choi CS; Kim HJ; Lee YH; Kaibuchi K; Kahn BB; Masuzaki H; Kim JK; Lee SW; Kim YB
Cell Metab; 2005 Aug; 2(2):119-29. PubMed ID: 16098829
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
Bourguignon LY; Singleton PA; Zhu H; Diedrich F
J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
16. Galphaq/11 signaling induces apoptosis through two pathways involving reduction of Akt phosphorylation and activation of RhoA in HeLa cells.
Ueda H; Morishita R; Narumiya S; Kato K; Asano T
Exp Cell Res; 2004 Aug; 298(1):207-17. PubMed ID: 15242775
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes.
Usui I; Imamura T; Babendure JL; Satoh H; Lu JC; Hupfeld CJ; Olefsky JM
Mol Endocrinol; 2005 Nov; 19(11):2760-8. PubMed ID: 15994203
[TBL] [Abstract][Full Text] [Related]
20. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
